The incidence of skin cancer is increasing worldwide and cutaneous squamous cell carcinomas (SCCs) are associated with considerable morbidity and mortality, particularly in immunosuppressed individuals ('carcinomatous catastrophy'). Yet, molecular mechanisms are still insufficiently understood. Besides ultraviolet (UV)-indicative mutations, chromosomal aberrations are prominent. As telomeres are essential in preserving chromosome integrity, and telomere erosion as well as aberrant spatial telomere distribution contribute to genomic instability, we first established telomere length profiles across the whole tissue and identified normal skin (10/30) harboring discrete epidermal sites (stem cell territories) of evenly short telomeres. Precancerous actinic keratoses (AKs) (17) and SCCs (27) expressed two telomere phenotypes: (i) tissue-wide evenly short to intermediate and (ii) longer and tissue-wide heterogeneous telomere lengths, suggesting two modes of initiation, with one likely to originate in the epidermal stem cells. Although tumor histotype, location, patient gender or age failed to distinguish the two SCC telomere phenotypes, as did telomerase activity, we found a trend for a higher degree of aberrant p53 and cyclin D1 expression with long/ heterogeneous telomeres. In addition, we established an association for the short/homogeneous telomeres with a simpler and the heterogeneous telomeres with a more complex karyotype correlating also with distinct chromosomal changes. SCCs (13) from renal transplant recipients displayed the same telomere dichotomy, suggesting that both telomere subtypes contribute to 'carcinomatous catastrophy' under immunosuppression by selecting for a common set (3, 9p and 17q) and subtype-specific aberrations (e.g., 6p gain, 13q loss). As a second mechanism of telomere-dependent genomic instability, we investigated changes in telomere distribution with its most severe form of telomeric aggregates (TAs). We identified a telomere length-independent but progression-dependent increase in cells with small telomere associations in AKs (17/17) and additional TAs in SCCs (24/32), basal cell carcinomas (30/31) and malignant melanomas (15/15), and provide evidence for a reactive oxygen species-dependent mechanism in this UV-induced telomere organization-dependent genomic instability.
INTRODUCTION
Skin cancer, the most common malignancy worldwide, encompasses non-melanoma skin cancers with keratinocyte-derived basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) and the neuroectodermal malignant melanoma (MM). The incidence of these tumors is rising rapidly and aggressive skin carcinomas are associated with considerable morbidity and mortality. 1 Forty percent of immunosuppressed transplant recipients develop premalignant or malignant skin tumors within the first 5 years and in these patients SCCs exceed the frequency of BCCs, which generally prevail in the normal Caucasian population; a situation also termed 'carcinomatous catastrophy'. 1, 2 Similarly, treatment of MMs with BRAF inhibitors accelerates skin carcinoma development, leading to the appearance of keratoacanthomas (KAs) and SCCs within only a couple of months in about 30% of these patients. 3 Thus, non-melanoma skin cancer and in particular skin SCCs comprise a major problem requiring better understanding of its development and progression to establish relevant novel therapeutic approaches.
Over the years, genetic profiles of SCCs have been established, demonstrating that in addition to specific mutations causing, for example, inactivation of the p53 tumor suppressor gene or activation of the Ha-ras oncogene (for a review see Boukamp 4 ), chromosomal aberrations may also be associated with specific genetic changes. These included loss of p16 correlating with loss of chromosome 9p21, [5] [6] [7] deregulation of cyclin D1 correlating with gain of chromosome 11q13 (Burnworth et al. 8 and Utikal et al., 9 and references therein), or copy number gain of c-Myc correlating with gain of chromosome 8q24. 10 The high frequency of chromosomal aberrations, that is, the generally complex karyotype of SCC 10-16 strongly argues for a high level of genomic instability. One potential mechanism for tumordependent genomic instability is proliferation-dependent telomere erosion. 17 Critically short telomeres lose their protective function 1 and are prone to chromosomal fusions, anaphase bridge formation and finally chromosomal breakage. This fusion-bridge-breakage cycle can lead to chromosome imbalance, gene amplification and non-reciprocal translocation. Commonly, short dysfunctional telomeres are recognized by the p53 tumor suppressor gene and this leads to permanent cell cycle arrest. 18 For tumor development, telomere length-dependent senescence has to be overcome. In skin carcinomas, mutational inactivation of p53 is a frequent and early event. 19 Thus, annulling the p53 fail-safe mechanisms may allow for telomere erosion beyond a critical length and with that for telomere length-dependent genomic instability.
We previously reported that changes in telomere distribution also induce telomere-dependent genomic instability. [20] [21] [22] Overexpression of the c-myc oncogene caused transient clustering of telomeres, that is, formation of TAs, which caused subsequent fusion-bridge-breakage cycles and new chromosomal aberrations. 22 In addition, TAs induced by constitutive expression of c-Myc were maintained throughout the cell cycle, suggesting that chromosomes that cluster because of TA formation are also distributed jointly during mitosis, thereby causing gains and losses of entire chromosomes in the respective daughter cells. 20 We now provide evidence that ultraviolet (UV) radiation is similarly able to induce TA formation and that this correlates with the establishment of new chromosomal aberrations. Thus, similar to UV-dependent telomere loss, UV-dependent changes in telomere distribution may contribute to genomic instability and thereby drive skin cancer progression.
RESULTS

Telomere lengths determines two tumor subgroups
It is suggested that critically short telomeres are causal for genomic instability; 23 thus, if induced in human skin by, for example, UV radiation, short telomeres may contribute to the initiation of skin cancer. To address this, we first investigated 30 samples of normal human skin. We have previously shown that telomere length can be measured successfully in tissue sections providing an even more accurate evaluation than common Southern blot analyses, owing to the possibility of distinguishing between different cell types in the skin. 24 We have now extended this analysis by carefully screening through full size tissue sections for variations in telomere length. Indeed, in 10 samples we identified discrete epidermal sites, consisting of 10-1000 basal cells with significantly shortened telomeres (Figure 1 ). Staining artifacts were excluded by rehybridization of the sections with chromosome 7 centromeric DNA and quantification of centromeres and telomeres (Supplementary Figure 1) . Importantly, neither dermal fibroblasts in the underlying stroma nor melanocytes within these specific epidermal sites exhibited short telomeres. As only stem cells are able to establish such discrete and long-lasting sites with all progenitor cells exhibiting the same short telomere length, stem cells are likely to represent the initially affected cell. It is noteworthy that all samples containing sites of accelerated telomere loss were derived from donors X50 years, thus arguing for an UV-acquired phenotype that correlates with age.
If these sites of accelerated telomere loss are relevant to skin cancer initiation, SCCs should exhibit a similar short telomere phenotype. We therefore established telomere length profiles of 27 human skin SCCs. For each tumor, 10 randomly selected areas (defined by hematoxylin and eosin staining) were chosen and telomere length was determined by measuring telomere signal intensity (TSI) in at least 25 Table 1) . Taken together, this demonstrates that only about 1/3 of the skin SCCs exhibit evenly short telomeres and may originate from stem cells initially affected by accelerated telomere loss while initiation of the heterogeneous telomere phenotype still remains obscure.
To determine whether telomere dichotomy was unique for SCCs, we also tested 21 BCCs. We found two similar profiles (Figures 2e and f and Supplementary Table 1) . Seven BCCs showed a homogeneous distribution and most of these were of intermediate telomere size, whereas 14 BCCs showed a heterogeneous distribution. However, it is noteworthy and in agreement with previous work 25 that the telomeres were generally longer in BCCs than in SCCs. For SCCs and BCCs, the telomere length phenotype did not correlate with tumor histotype and location, or patient age and gender (Supplementary Tables 3 and 5) .
In immunosuppressed transplant recipients, SCCs are more frequent and aggressive and develop within a rather short latency period. 1 To determine whether these tumors may be of a specific telomere subtype, we additionally investigated skin SCC from a UK cohort consisting of eight immunocompetent (IC) patients and 13 immunosuppressed RT recipients. These tumors have been genetically profiled previously as part of a larger series; 13, 14 however, only a subset of this series was analyzed here, specifically those tumors with sufficient cryopreserved tissue available, to avoid the telomere hybridization artifacts associated with the use of archival material. As in the previous series, the IC SCCs provided a clear telomere dichotomy, with four SCCs exhibiting a Figure 1 . Sites of telomere erosion in normal human skin. Telomeres were stained with a telomere-specific PNA probe (Dako A/S) (red) and centromeres with a PNA probe specific for chromosome 7 (green). Staining for vimentin (gray) was performed to mark melanocytes in the basal layer of the epidermis and fibroblast in the underlying dermis. Nuclei are counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI) (blue). The dotted line indicates the basement membrane separating the epidermis and dermis. The straight line indicates the border between the epidermal site with short telomeres (very low red staining for telomeres) and the 'normal' epidermis with long telomeres (intense red staining of telomeres). Note that the telomeres of the melanocyte (marked with arrow) within the epidermal site of short telomeres and the dermal fibroblasts underneath that site exhibit long telomeres. Bar ¼ 10 mm. 
3pter-3pcen, 8pter-8pcen, 9pter-9pcen ND Figure 3a ). Only two of the homogeneous tumors exhibited a good level of telomerase activity, whereas the telomerase was hardly detectable in the other three tumors. The same was seen for the group of SCCs with heterogeneous telomeres. In addition, we analyzed 14 AKs. Owing to tissue restrictions, TRAP activity was investigated in full-thickness sections containing normal epidermis and dermis, as well as AK. In view of its impact on TRAP activity, 27 transformation-dependent upregulation should be seen. However, only some marginal activity could be detected in a few samples (Figure 3b ). In line with previous studies, 5, 25, 28, 29 these findings may thus suggest that telomerase is not obligatorily upregulated in either premalignant skin lesions or in skin SCCs, even if these have short telomeres. Furthermore, no correlation was observed between telomerase status and the amount of tumor stroma, tumor differentiation and/or necrosis.
Aberrant p53 and cyclin D1 are frequent for cutaneous SCCs Mutational inactivation of p53 is an early if not an initial event in skin carcinogenesis, 19 and abrogation of the p53 checkpoint could explain the establishment of short telomeres. To explore this relationship, we used immunostaining of p53 as a surrogate for stabilized and potentially mutated p53 protein. 30 Analyzing 26 SCCs, the number of positive nuclei was used to classify samples into four categories: no ( À ), low (o30%; þ ), moderate (30-70%; þ þ ) or high (470%; þ þ þ ) expression. P53 was detected in 65% of the tumor samples, with 10 (38%) showing low, 3 (12%) moderate and 4 (15%) high numbers of p53 nuclei (Figures 4a and c) , thereby confirming the general frequency of B60% of p53 mutations in SCCs (for a review see Boukamp 4 ). Concerning a correlation between p53 expression and telomere length phenotype, the homogeneous SCCs were more often among the 'low expressers', whereas moderate or high expression appeared more frequent in SCCs of the heterogeneous telomere phenotype (Table 1) .
A second frequent and early event is the upregulation of cyclin D1 (reviewed in Burnworth et al. 8 ). In agreement with our previous data, cyclin D1 overexpression was seen in 81% of the tumors. Interestingly, the distribution (same categories as above) was similar as for p53 with a trend for a higher number of positive nuclei per tumor in tumors with heterogeneous telomeres (Figures 4b and c and Table 1) , and thus demonstrating a significant correlation between p53 and cyclin D1 expression (P ¼ 0.0084, Pearson's r ¼ 0.5057).
CGH analysis distinguishes genetic SCC subgroups
To determine the consequence of the telomere phenotype on the genetic makeup, we performed comparative genomic hybridization (CGH). 31 From the German cohort, 14 of 16 analyzed SCCs The respective telomere length phenotype is marked above. (a) SCCs showed a high diversity of telomerase activity in both telomere length subtypes, also containing tumors without detectable telomerase activity. (b) In AKs, telomerase activity was hardly detectable. HaCaT cells served as positive control 44 and were enclosed untreated ( þ ) or as negative control treated with RNase ( À ). IC ¼ internal control.
were instructive. As shown in Table 1 , all SCCs with heterogeneous telomeres commonly exhibited highly complex karyotypes (5-17 aberrations) with multiple gains as well as frequent loss of chromosomal material. In contrast, the tumors with homogeneous telomeres exhibited relatively simple karyotypes (1-5 aberrations) and only rare chromosomal losses. Nevertheless, gain of 17 or 17q and 20 or 20q in the homogeneous (4/4 and 2/4, respectively) as well as in the heterogeneous group (8/8 and 5/8, respectively) were common for both groups. In addition, common aberrations in the heterogeneous group were gain of 7q and 16q (63% each), 9q (50%), 5p, 22q, and 8p loss (38% each).
The UK SCCs exhibited completely different genotypes. First, the number of aberrations was generally increased, potentially due to the more sensitive array CGH analysis used, 13 but the number of aberrations was still lower in the homogeneous IC SCCs (6-7) as compared with the heterogeneous ones (8) (9) (10) (11) (12) , with one exception (IC SCC J) exhibiting 415 aberrations and a highly fragmented chromosome 2 14 suggestive for a case of chromotrypsis. 32 Second, the aberration profiles were much more diverse. However, recurrent genetic aberrations supported the identity of the different groups. Loss of 2q and 3p (75%), 17q, 10 (50%), and gain of 8p (50%) characterized the homogeneous group, whereas loss of 8p, 9p (100%), 13q (50%), and gain of 8q (75%) and 15q (50%) were recurrent in the heterogeneous group. In the 10 genetically analyzed RT tumors a shift was seen. In the homogeneous group, four SCCs showed 8-10 aberrations and one only showed 3 aberrations. In one exceptional case, nearly all (22) chromosomes were involved in aberrations (RT SCC H; Purdie et al.
)
. As 3p (83%) and 17 q loss (50%) similarly dominated in the homogeneous IC SCCs, a common genesis may be indicated. In addition, the RT homogeneous SCCs exhibited recurrent aberrations such as loss of 9p, 13q (67% each), 4 (50%), and gain of 5p (50%) suggestive for a common selection process. The heterogeneous RT SCCs, on the other hand, showed only little overlap with their IC counterparts (9p loss in 50%). Instead, selection for loss of 3p and 17 (50%) rather reflected the profile of the homogeneous RT SCC. In addition, gain of chromosome 6p (75%) was unique for this group of tumors. Taken together, the genetic data confirm the existence of genetically defined subgroups of skin SCCs on the basis of their telomere profiles in two independent cohorts, thereby suggesting the importance of telomere length regulation for determining the genetic evolution of the skin SCCs. Despite all heterogeneity, some recurrent aberrations, for example, loss of 13q and 17, and/or gain of 6p and 5p, may point to and be favorable for the accelerated and more aggressive growth upon immunosuppression, and thus may be relevant candidate lesions for future investigations.
Telomere distribution is altered with tumor progression Besides telomere length, aberrant telomere distribution with its most severe form of TAs can also induce genomic instability. [20] [21] [22] To determine whether this may also contribute to skin cancer, normal skin, AKs, SCCs, BCCs and MMs were investigated. For each tissue, 10 areas were randomly chosen and telomere distribution was determined in B15 cells (each) in a three-dimensional configuration for each nucleus. In agreement with the normal skin samples analyzed previously, 24 the eight samples included here revealed a normal telomere distribution with telomeres being evenly distributed throughout the nucleus (Supplementary Figure 3A) . Occasional clustering of two or three telomeres was seen in 5-16% of the cells (Supplementary Figure 3D and Figure 5a) . Although regarded as a sign of normal low-level telomere movement (33) (Figure 5b and Table 2 ) and with one exception also exhibited some TAs (1-3%). In addition, one AK showed an increased amount of TAs (7%; Figure 5b, AK11) .
The majority of SCCs (24/32) showed a similar phenotype to the one exceptional AK with 25-47% of aberrant cells and 5-16% of TAs ( Figure 5c and Table 2 ). Eight SCCs differed. One exhibited a good number of TAs (4%) despite an otherwise rather normal frequency (19%) of aberrant cells (SCC 08), whereas the other seven had no or very few TAs (0-2%) together with a rather low frequency (10-32%) of aberrant cells (Figure 5c ). Three of these latter were classified as initial SCCs, that is, tumors that had not yet penetrated the basement membrane, whereas the other four could not be related to a common histotype or patient-specific characteristics (Supplementary Table 3 ). Three KAs, SCC-like but in principle spontaneously regressing skin tumors, showed the same aberrant telomere organization as the majority of SCCs (Figure 5c ).
BCC and MM also show aberrant telomere distribution To determine whether aberrant telomere distribution may be a more general principle, we additionally investigated BCCs as a second though generally non-metastatic epidermal skin tumor and MMs as highly metastatic skin tumor of neuroectodermal origin ( Figure 5 and Table 2 ). In 24 of 31 analyzed BCCs, an increased number of aberrant cells (30% up to 63%) was detected and all of these contained a substantial rate (5.5 to 15%) of TAs (Figure 5d ). With the exception of one (BCC 01 with only 2.5% TAs), the other five BCCs also showed an increased rate of TAs (4-11%), although the overall number of aberrant cells was only slightly increased, by 23-29% (Figure 5d ). Histopathologically, these BCCs did not differ, and thus the amount of aberrant cells and/or TAs did not correlate with a specific BCC subtype nor was there any correlation with gender, age or location of the BCCs (Supplementary Table 5 ). For MMs the situation was unambiguous. All MMs showed a high number of aberrant cells (37-66%) and an increased frequency of TAs (4-21%; Figure 5e and Table 2 ), demonstrating that aberrant telomere distribution with the extreme of TA formation is a characteristic of all three skin tumor types.
A decisive role for UV in modulating telomere distribution For all three tumor types, UV radiation is the principal carcinogen, 4 and as they all show TAs, UV radiation may be the common inductor. To address this, we utilized HaCaT keratinocytes as a model for early skin carcinogenesis. These cells contain UV-indicative p53 mutations and chromosomal aberrations,that is, loss of 3p and 9p loss and gain of 3q gain, 33 ,34 similar to those described above. As the c-myc oncogene is frequently upregulated in SCCs 10 and by itself can induce TAs, 20,33,34 we additionally included HaCaT cells constitutively expressing c-Myc (HaCaT-myc; Cerezo et al. 35 ). All cells were irradiated with 50 J/m 2 UVC and TA formation was determined after 48 h. Although unirradiated HaCaT cells showed evenly distributed telomeres (Supplementary Figure 1E) , UV radiation induced a twofold increase in TAs (Figure 6a ). HaCaTmyc cells, as expected from their c-Myc status, exhibited a constant low number of TAs already in control cultures. Upon radiation, however, the number of TAs increased in a dose-dependent manner with a maximum of 21.5% at 50 J/m 2 ( Figure 6b ). It was noteworthy that, whereas control cells showed only one TA per cell, UV radiation commonly induced multiple TAs per cell, a feature also characteristic for the SCCs in situ (Figure 6c ).
As we previously established a role for the c-myc oncogene in TA formation, we asked whether UV-dependent induction of TAs may also be regulated by c-myc. Although UV induced a timedependent increase in c-myc RNA and protein (Figure 6d and data not shown), its relevance for UV-dependent TA formation could be excluded by inhibiting protein biosynthesis by means of 30 min preincubation with cycloheximide. This did not hinder TA induction. The UV-induced number of TAs considerably exceeded that of untreated controls (Figure 6f ). In addition, this study indicated that de novo protein synthesis was not required for UVdependent TA formation.
Another potential inductor may be UV-dependent generation of ROS. Accordingly, cells were investigated by fluorescence-activated cell sorting analysis for ROS production 2, 12 and 24 h after UVC radiation (50 J/m 2 ). Using 2 0 ,7 0 -dichlorohydrofluorescein diacetate as an indicator of ROS induction, we observed a timedependent increase in fluorescence signals, thus demonstrating that ROS is induced and increases in a time-dependant manner in HaCaT-myc cells after UV radiation (Figure 6g) . To determine the role of ROS in TA formation, we next blocked the UV-induced ROS formation by preincubating the cultures with the antioxidant glutathione (GSH) for 24 h and irradiating them with 50 J/m 2 UVC. Fluorescence-activated cell sorting analysis performed 2, 12 and 24 h after irradiation demonstrated a significantly reduced amount of ROS (20.1% at 2 h, 19.4% at 12 h and 28.6% at 24 h; Figure 6g 0 ). Importantly, telomere analysis performed with cells from the different treatment regimens showed the expected increase (twofold) in TA formation upon UV radiation, whereas TA formation was completely abolished in HaCaT-myc cells pretreated with GSH (Figure 6h) , that is, when ROS induction was inhibited supporting an ROS-based mechanism of UV-dependent TA induction. Interestingly, incubation with GSH also abolished the constitutive low-level TAs in the GSH-treated but unirradiated HaCaT-myc control cells, suggesting that c-Myc-induced TA formation may also be an ROS-dependent mechanism (Figure 6h) .
To address the consequence of TA formation on genomic instability, UV-irradiated HaCaT-myc cells were subjected to multifluor fluorescence in situ hybridization analysis 36 and assayed for chromosomal changes. Two independent experiments demonstrated a three-to fivefold increase in new chromosomal aberrations (Supplementary Figure 4 and Supplementary Table 2) . As there was no overlap for individual translocations between different metaphases of the same culture or between the two different experiments, selection for pre-existing subpopulations was unlikely. Instead, the data argue for a tight correlation between TA induction and induction of chromosomal rearrangement.
TAs occur independently of telomere length Finally, we asked how the appearance of TAs would relate to telomere length. We, therefore, correlated the TSI per cell with the appearance of TAs in the same cells. As exemplified for an individual SCC and BCC, both showed TAs in cells with short and long telomeres (Supplementary Figures 5A and B) . Nevertheless, bias for longer telomeres was seen in the SCC. This was confirmed with the combined data sets of six tumors showing an abnormal distribution. BCCs (n ¼ 11), on the other hand, exhibited a comparatively even distribution (Supplementary Figures 5C and D) . Because of the wide range of telomere length associated with TAs, however, telomere distribution-dependent genomic instability appears largely independent of telomere length.
DISCUSSION
Mounting evidence exists of a causal role for telomere dysfunction in a number of degenerative disorders. 37 Similarly, telomere Abbreviations: AK, actinic keratose; BCC, basal cell carcinoma; KA, keratoacanthoma; SCC, squamous cell carcinoma; TA, telomeric aggregate.
Telomeres and human skin cancer C Leufke et al biology has a critical and complex role in cancer with replicative telomere attrition and its consequence of dysfunctional telomeres as one important initial mechanism of genomic instability (reviewed in Xu et al.
38
). We here addressed the role of telomeres in skin cancer initiation and progression, and provide evidence that the tumor-wide telomere length distribution profile is able to distinguish two subtypes of SCCs: one exhibiting short-to mediumsized telomeres and a tumor-wide rather similar telomere length, with the other being characterized by longer telomeres and tumorwide heterogeneous telomere lengths. This telomere dichotomy is not restricted to SCCs but already seen in the precursor lesions, the AKs, as well as in the second type of skin carcinoma, the BCC.
This suggests that aberrant telomere loss can be an early event in skin carcinogenesis, although it may only account for a subfraction. It is also worth noting that we found skin samples from elderly donors representing sites of evenly short telomeres within an epidermis of otherwise long telomeres. As only stem cells can contribute to long-term epidermal regeneration, this implies that these sites represent stem cell territories in which the primarily affected stem cell stabilized with an overall reduced telomere length and continued to contribute to epidermal regeneration by providing all progenitor cells with the same short telomeres. It, therefore, is tempting to suggest that these AKs, SCCs and BCCs characterized by a homogeneously short/ intermediate telomere phenotype originated in stem cell territories with the stem cell as the tumor-initiating cell. However, this is not the only and apparently dominant scenario in skin carcinogenesis. More than 50% of the tumors show long/heterogeneous telomere length profiles. Also, this telomere phenotype is found in AKs, suggesting that AKs are not precursor lesions for one specific SCC subtype. Instead, two mechanisms of tumor initiation are implied and it presently remains unclear by which event and from which cell (stem or progenitor cell) tumors of the heterogeneous telomere phenotype develop. Further support for the telomere phenotype representing distinct SCC subtypes stems from our genetic analyses. SCCs characterized by a homogeneous telomere phenotype generally exhibited less genetic aberrations. This was particularly obvious in the German cohort where these tumors were characterized by rather simple karyotypes (1-5 gains and rare losses), whereas SCCs with an intermediate/long heterogeneous telomere phenotype show more complex aberration patterns with 5-17 gains and commonly several losses. Similarly, the SCCs (from the IC patients) derived from the British cohort, although overall more aberrant, were consistent with this classification and further specified by sets of recurrent changes (450%), such as 2q, 3q loss in the homogeneous tumors, and 8p, 9p loss and 8q gain in the heterogeneous ones. Support for karyotypic dichotomy in human skin SCCs was already provided by Jin et al. 11 Similarly, single-nucleotide polymorphism array analysis identified SCCs with few (1-5) and numerous (6-13) allelic imbalances.
14 Unfortunately, the telomere status was not determined in these SCCs.
Interestingly, SCCs derived from immunosuppressed RT recipients showed the same telomere dichotomy with about half exhibiting the long/intermediate heterogeneous and half the short/intermediate homogeneous telomere phenotype supporting a non-biased progression of all precursor lesions. It was suggested that telomere length is increased in RT SCCs. 28 It is indeed noteworthy that the majority of heterogeneous tumors had long telomeres and the sole homogeneous tumor with long telomeres was seen in the group of RT SCCs. In accord with the non-biased telomere phenotype, the genotypic analysis also failed to support selection for a specific genetic subtype under immunosuppression. 13 Loss of chromosomes 3p, 9p and 17q predominating in our cohort are common in general (see also Dworkin et al. 16 ), and it remains to be seen whether and how the unique recurrent aberrations assigned to the two telomere groups, for example, 6p gain or 13q loss, may contribute to the increased growth and aggressiveness of the RT SCCs. Clearly, this now requires the analysis of a high number of SCCs to further strengthen these findings. Furthermore, it will be of outmost interest to determine whether metastasis may be related to a specific telomere/genetic subtype. Thus, confirming these data in a larger set of tumors may well have prognostic and therapeutic implications.
As a second telomere-dependent mechanism of genomic instability, we investigated aberrant telomere distribution with the most severe phenotype of TAs. In contrast to telomere length regulation, aberrant telomere distribution seems to gradually develop with tumor progression, terminating in the formation of large aggregates. Although commonly arranged in non-overlapping territories, the appearance of a low frequency of small random telomere associations is suggestive for a constant low level of telomere movement and is described as a common feature of normal cells. 39 However, in AKs the number of such small associations is strongly increased. Bigger aggregates, TAs, on the other hand, are restricted to bona fide tumors, KAs, SCCs, BCCs and MMs. This may suggest that constraints on the generally tight spatial regulation of telomeres in normal cells are released early during transformation, whereas the formation of large aggregates requires additional genetic alterations.
We have previously shown that deregulated c-Myc causes TA induction. [20] [21] [22] We now add that TAs are also induced upon UV radiation and that this is independent of c-Myc upregulation. Instead, we provide evidence that ROS is the actual trigger for the UV-induced telomere deregulation. Inhibiting ROS by means of pretreatment with GSH not only prevented de novo induction but also hindered c-myc-induced TA formation. We also have evidence that shelterin proteins and components of the linker of cytoskeleton and nucleus complex are involved. Thus, unraveling all molecular targets and their mode of action during TA formation may well provide a basis for counteracting this telomeredependent process of genomic instability.
It was recently reported that TAs progressively formed during cellular senescence of mesenchymal stem cells and colocalized with gH2AX, indicating them as sites of DNA damage. 40 We did not detect TAs during skin aging in either the epidermal keratinocytes or dermal fibroblasts, 24 but demonstrated TA induction as a consequence of c-Myc-induced genomic instability, [20] [21] [22] and here as a consequence of UV radiation in a c-Myc-unrelated but ROS- dependent manner. Damage foci, as measured by gH2AX or p53BP1 staining, are transiently induced upon UV radiation; however, we have no evidence that TAs are specifically targeted. TAs appear as stable associations that accumulate different numbers of telomeres and as a consequence also different numbers of chromosomes, thus allowing for an easy exchange of chromosomal material as indicated by the rapid induction of numerous new chromosomal translocations.
Taken together, we here demonstrate for the first time that telomere length distribution distinguishes two types of genetically distinct skin SCCs and therefore suggest two different mechanisms of tumor initiation. Although the short/homogeneous telomere length profile argues for a common initiating cell, an epidermal stem cell that has suffered from accelerated telomere loss, the long/heterogeneous telomere length profile points to telomere length-independent initiation in a cell that still has to be defined. In this latter case, which may even represent the majority of skin SCCs, tumor development seems to be multifocal with possibly different proliferation rates at different sites-leading to variations in telomere lengths and possibly also genetic heterogeneity. SCCs in immunosuppressed recipients are of both subtypes and exhibit complex aberration profiles, thus suggesting for general immunosuppression-caused genetic progression. Whether this will also account for metastasis has yet to be addressed. Telomere organization, on the other hand, seems to be altered in most skin tumors (SCC, BCC and MM) and may be indicative for constitutively ongoing genomic instability. Thus, inhibiting telomerase to induce telomere length-dependent cell death may only be advised for a fraction of SCCs. Suppression of aberrant telomere movement and in particular TA formation, on the other hand, by, for example, stabilizing telomeres through administering G-quadruplex inhibitors 41 may be a favorable addition for combating all skin cancer progression.
MATERIALS AND METHODS
Tissue samples
Archival or cryopreserved material was derived from AKs, KAs, SCCs, BCCs, MMs and normal skin with each tissue being defined by histopathology.
Normal skin was obtained from 38 donors (age of 7-90 years) from different locations of the head and neck as well as trunk. AKs originating from 17 patients are specified in Supplementary 
Cell culture
HaCaT and HaCaT-myc cells were routinely cultured as described previously. 30 For three-dimensional analysis, cells were seeded onto glass slides and irradiated with 10, 20, 30, 40 or 50 J/m 2 UVC at a confluence of B80%. After 48 h, the cells were fixed in 3.7% formaldehyde for 10 min, washed in phosphate-buffered saline (PBS) and stored for further analysis.
For genetic analyses, the cells were cultured in 10-15 cm dishes and irradiated as described. The cultures were maintained for another 14 to 18 days to allow for sufficient metaphases. Metaphase spreads were performed following standard protocols.
For detection of ROS, trypsinized HaCaT-myc cells were incubated in 500 ml of a 1:1000 diluted stock solution (2.4 
Three-dimensional FISH analysis of tissue sections
Telomere staining was performed as described by Krunic et al. 24 Briefly, frozen tissue sections were fixed for 10 min in 3.7% formaldehyde, washed with 1 Â PBS, dehydrated by serial ethanol, air dried and hybridized with Cy3-labeled PNA (Peptide Nucleic Acid) probe (PNA Telomere FISH Kit K5326; Dako A/S, Lustrum, Denmark). The slides were washed and covered with antifade solution (VectaShield; Vector Laboratories Inc., Burlingame, CA, USA) containing 4 0 ,6-diamidino-2-phenylindole. Formalin-fixed, paraffin-embedded tissue sections were dewaxed in xylene and rehydrated in descending ethanol series. After the slides were washed in PBS and incubated in 0.5% Pepsin/PBS for 5 min at 37 1C, they were refixated (2 min) and again washed in PBS. Starting with the ascending ethanol series, the slides were treated as described above. Detailed information on Image acquisition, deconvolution and image processing are enclosed in the figure legend of Supplementary Figure 1 . Mean TSI was calculated as described 24 and GraphPad Prism 4.6 (GraphPad Software, San Diego, CA, USA) used for further data handling and statistical analysis. Statistical significance was determined using t-test with a significance level of P ¼ 0.05 (*0.01oPo0.05, **Po0.01).
Simultaneous immunofluorescence
To differentiate between epidermal keratinocytes and vimentin-positive melanocytes and dermal fibroblasts, telomere hybridization was followed by immunofluorescence staining for vimentin (Progen, Heidelberg, Germany) detected with dichlorotriazinylaminofluorescein-conjugated anti-guinea-pig antibody (Dianova, Hamburg, Germany), as described previously. 24 To exclude that telomere erosion would be a staining artifact, the same sections were rehybridized with fluorescein isothiocyanate-conjugated centromere 7 PNA probe dissolved 1:10 in telomere Cy3-conjugated PNA probe (Dako, Glostrup, Denmark).
Immunohistochemistry
Immunohistochemistry was performed as described by the manufacturer with the EnVisionTM þ Dual Link System-HRP (3,3-diaminobenzidine) Detection Kit (K5008; Dako Cytomation, Glostrup, Denmark). Heat-induced epitope retrieval was performed in 10 mM citrate buffer for p53 and Tris/ EDTA for cyclin D1 staining at 95 1C for 40 min or 10 min, respectively. Primary antibodies (anti-p53: 1:100 (Epitomics, Burlingame, CA, USA) and anti-cyclin D1: 1:300 (Sigma-Aldrich, Deisenhofen, Germany)) were incubated for 90 min at room temperature or overnight at 4 1C. Dextran polymer conjugated with horseradish peroxidase was used for 30 min and the peroxidase reaction was developed in 3,3-diaminobenzidine chromogen solution in 3,3-diaminobenzidine buffer substrate. Sections were counterstained in hematoxylin, mounted in Permafluor mounting medium and evaluated under a Light Microscope AX-70 (Olympus, Hamburg, Germany).
Comparative genomic hybridization
For CGH analysis, the tumor tissue, as predetermined on hematoxylin-and eosin -stained sections, was dissected from subsequent serial sections (25 mm) to ensure for 450% tumor cells in the analyzed DNA.
DNA isolation, CGH analysis, image acquisition and processing were performed as described previously. 42, 43 Briefly, 300 ng biotin-labeled tumor DNA, 300 ng digoxinin-labeled reference DNA (male donor) together with 50 mg Cot1 DNA and 50 mg salmon sperm DNA were hybridized to normal metaphase spreads (46, XY) for 43 days. The biotin-labeled tumor DNA was detected with avidin-fluorescein isothiocyanate-and the digoxigeninlabeled control DNA with Cy3-conjugated antibody. Images were taken for each fluorochrome with appropriate filter sets using an epifluorescene microscope (DM-RXA; Leica Mikrosysteme GmbH, Bensheim, Germany) equipped with cooled, charged, coupled device camera (Sensys; Photometrics, Tucson, AZ, USA). Chromosomes were karyotyped using the inverted 4 0 ,6-diamidino-2-phenylindole banding pattern and evaluation of the fluorescein isothiocyanate/Cy3 ratio profiles of 10-15 metaphase spreads were performed using the Q-CGH software (Leica
